Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
Lateral flow rapid test development, manufacturing and regulatory services
Abingdon Health is a contract development and manufacturing organisation specialising in lateral flow rapid diagnostic tests. It provides end-to-end services spanning assay development, scale-up manufacturing, regulatory approval and commercialisation support across healthcare, animal health and plant health. The…
Point-of-care HPV self-testing for cervical cancer screening
10zyme is an early-stage medical technology company developing a point-of-care self-test for high-risk human papillomavirus, integrating synthetic biology with machine learning to deliver instant results without laboratory processing. Its test screens for all 14 high-risk HPV types linked to cervical cancer,…
Synthetic aptamer binders as antibody alternatives for research
Aptamer Group is a life sciences company developing synthetic nucleic acid-based affinity binders as high-performance alternatives to antibodies. Selected via its proprietary SELEX-derived platform, the binders are customised against protein, peptide, cell, and small molecule targets for applications across drug…
Inkjet microarray printing instruments and contract array services
Arrayjet is a manufacturer of inkjet-based microarray printing instruments and a provider of contract array research and manufacturing services. The company's patented non-contact dispensing platform prints proteins, antibodies, nucleic acids, and small molecules onto solid substrates for applications including…
DNA identification and STR-based cell-line authentication services
NorthGene is Biofortuna's genetic testing brand, operating from accredited laboratories in Deeside, Wales. Its services include DNA relationship and forensic identification testing, plus short tandem repeat profiling for cell-line authentication. Research customers can request mycoplasma detection, culture mixture…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free soluble nanoarray technology enables simultaneous quantification of up to 200 RNA and DNA targets from low-input samples within one hour.…
Polymer-based rapid diagnostic technology for bacterial and fungal infections
Molecular Titans is a University of Bradford spin-out developing a patented polymer nanotechnology platform for rapid infection diagnosis. Its thermoresponsive polymers bind selectively to bacterial and fungal pathogens, producing a measurable signal within minutes rather than days. Initial applications include…
AI platform combining retinal imaging and genomics for inherited eye disease diagnosis
Eye2Gene is an AI-powered precision ophthalmology platform combining retinal imaging with genomic analysis to accelerate diagnosis of inherited retinal diseases. Using a neural network ensemble trained on tens of thousands of multimodal retinal scans, the platform predicts the likely causative gene behind a patient's…
Predictive genetic tests for cancer and cardiovascular disease
GENinCode is a clinical-stage diagnostics company developing polygenic risk assessment tests for cardiovascular disease and ovarian cancer. Its portfolio includes CE-marked molecular tests for coronary artery disease, familial hypercholesterolaemia and thrombosis risk, alongside the ROCA test for ovarian cancer…
Therapeutics and blood biomarker tests for ALS
Vesalic develops therapeutic and diagnostic approaches for amyotrophic lateral sclerosis (ALS), focusing on the potential role of metabolic dysfunction outside the nervous system. Its preclinical programmes include a treatment candidate designed to address toxic cargo carried by exosomes to motor neurons, alongside a…
Rapid point-of-care molecular testing for sexually transmitted infections
Binx Health is a diagnostics company that develops and manufactures a rapid point-of-care molecular testing platform for sexually transmitted infections. Its benchtop instrument and single-use cartridges detect the genetic material of chlamydia and gonorrhoea from patient samples in around 30 minutes, allowing…
Rapid microfluidic antimicrobial susceptibility testing for clinical laboratories
iFAST Diagnostics is a biotechnology company developing microfluidic instruments for rapid antimicrobial susceptibility testing of bacterial infections. Its platform uses electrical measurements of individual bacteria following antibiotic exposure to determine susceptibility and minimum inhibitory concentrations in…